A Study to Evaluate the Effectiveness and Safety of TAK-491(Azilsartan Medoxomil) and Chlorthalidone Combined in One Tablet (40/12.5 and 40/25 mg) in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure on Treatment With TAK-491 40 mg Alone
This study has been completed.
Takeda Global Research & Development Centre (Europe) Ltd.
Information provided by (Responsible Party):
Takeda Global Research & Development Center, Inc. ( Takeda Global Research & Development Centre (Europe) Ltd. )
First received: October 18, 2011
Last updated: January 18, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||January 2013|
|Primary Completion Date:||January 2013 (Final data collection date for primary outcome measure)|